NICE clinical guideline for epilepsy
The NICE clinical guideline for epilepsy advise to “Provide the person with epilepsy, and their family or carers if appropriate, with a copy of their care plan, which includes details of their care and support as discussed and agreed with the person, and their family or carers if appropriate.”1
Examples, guidance and useful resources around individual buccal midazolam care plans are available from Young Epilepsy and Epilepsy Action.
1. National Institute for Health and Care Excellence (NICE). Epilepsies: Diagnosis and management- information for the public. Available from: https://www.nice.org.uk/guidance/ng217https://www.nice.org.uk/guidance/cg137/resources/epilepsies-diagnosis-and-management-pdf-35109515407813 The information on this page is for Healthcare Professionals' use only. Please do not share with patients and/or their carers.
ADVERSE REACTIONS SHOULD BE REPORTED
Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/.
Adverse events should also be reported to Neuraxpharm UK Ltd by:
- Email: pv-uk@neuraxpharm.com
- Phone number: +44 330 128 0919
